All of us Vs Keratoconus

Members Login
Please log in to join the chat!
Post Info TOPIC: Intacs Gains FDA Designation as Corneal Implants

Date: Mon Jan 9 4:25 AM, 2006
Intacs Gains FDA Designation as Corneal Implants

Press Release from Addition Technology regarding Intacs:

Intacs Gains FDA Designation as "Corneal Implants"

Des Plaines, IL (Jan. 4, 2006) - The U.S. Food and Drug Administration
has granted Addition Technology, Inc., the use of the term "corneal
implants" to describe Intacs, heretofore referred to as "prescription

"We are pleased with the FDA's recognition of Intacs as a therapeutic
device. Surgeons around the world have been utilizing Intacs as a
problem-solver for keratoconus and ectasia in corneal and refractive
and this designation assists in clarifying the appropriate positioning.
saw us report our twelfth consecutive quarter of double-digit sales
said William Flynn, chief executive officer of Addition Technology.

"The positioning of Intacs as a therapeutic device will result in new
of sales and growth in 2006," predicted Flynn. "As Addition Technology
achieved critical mass, we look forward to further expanding the
benefit of
Intacs for surgeons and their patients around the globe. Intacs is also
beginning to be recognized by refractive surgeons as a safe alternative
the two to three percent of mildly nearsighted patients desiring
surgery for whom tissue ablation or intraocular surgery are not ideal."

Addition Technology, Inc., a privately held company, manufactures
the only additive corneal implant approved by the U.S. Food and Drug
Administration for both keratoconus and myopia. Intacs also are
approved for
use in Europe, Asia, Mexico and parts of Latin America. For more
information, visit

-- Edited by QuintriX at 20:33, 2006-03-24

Page 1 of 1  sorted by
Quick Reply

Please log in to post quick replies.

Post to Digg Post to

Knowledge Works